K-numberK252005
Device nameLivi Device
ApplicantLiviwell, Inc.
Product codeHEB
Device classClass II
Decision dateMar 20, 2026
DecisionSubstantially Equivalent
Regulation884.5470
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Livi Device is an over-the-counter, single-use, non-sterile intravaginal absorptive device made of polyurethane foam with a flower/tulip shape. It is intended for insertion into the vagina following sexual intercourse to absorb semen or other vaginal discharge for up to 15 minutes, and explicitly does not prevent pregnancy or protect against sexually transmitted infections.

Technological characteristics

The Livi device uses polyurethane foam (versus cotton/viscose in the predicate), has a flower-shaped design with three petals and smooth rounded tip (versus cylindrical bullet-tip tampon), features a polyethylene applicator (versus cardboard), and uses multi-layer laminate packaging with PET outer wrapper (versus polyethylene and PET). Both are single-use, non-sterile, intravaginal absorptive devices with light absorbency (<6g) and cotton/polyester removal strings.

Test standards cited

ISO 10993-5:2009 (cytotoxicity), ISO 10993-10:2021 (skin sensitization), ISO 10993-23:2021 (vaginal irritation), ISO 10993-11:2017 (acute systemic toxicity), 21 CFR 801.430 (absorbency testing via Syngyna method), and FDA guidance documents on menstrual tampons and pads (July 27, 2005) and biological evaluation of medical devices (September 4, 2020).

Substantial equivalence argument

The Livi device is substantially equivalent because it shares similar technological characteristics with predicate K241064 (intravaginal placement, absorbent material, single-use, non-sterile design) and performs comparable safety and effectiveness testing. Although intended for post-coital absorption rather than menstrual use, the differences do not raise new safety or effectiveness questions, as risks from potential misuse are adequately addressed through labeling and demonstrated user comprehension in clinical studies.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →